TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014
TCL Archive Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed May 10, 2013